Skip to main content
. 2016 Mar 30;12(3):e1005955. doi: 10.1371/journal.pgen.1005955

Table 2. Associations between MKK7 rare polymorphisms and lung cancer risk.

MKK7 SNPs Discovery set Validation set I Validation set II Pooled analysis b
Case n (%) Control n (%) Adjusted OR (95% CI) a Case n (%) Control n (%) Adjusted OR (95% CI) a Case n (%) Control n (%) Adjusted OR (95% CI) a Case n (%) Control n (%) Adjusted OR (95% CI) a
p. Glu116Lys (rs28395770G>A) 1559 1679 1949 1957 1508 1545 5016 5181
Codominant model c 4417.3 5315.2 4037.6 13824.3
    Glu/Glu 1437(92.2) 1638(97.6) 1.00 (ref.) 1786(91.6) 1908(97.5) 1.00 (ref.) 1373(91.0) 1495(96.8) 1.00 (ref.) 4596(91.6) 5041(97.3) 1.00 (ref.)
    Lys/Glu 111(7.1) 38(2.3) 3.33(2.29–4.86) 140(7.2) 42(2.1) 3.53(2.48–5.01) 119(7.9) 45(2.9) 2.83(1.97–4.05) 370(7.4) 125(2.4) 3.23(2.62–3.98)
    Lys/Lys 11(0.7) 3(0.1) 3.94(1.09–14.3) 23(1.2) 7(0.4) 3.52(1.50–8.26) 16(1.1) 5(0.3) 3.26(1.16–9.14) 50(1.0) 15(0.3) 3.75(2.09–6.71)
Fisher test P value 4.12×10−12 7.99×10−16 8.98×10−11 1.09×10−36
Additive model c 4416.9 5317.9 4037.5 13829.6
    Lys/Lys vs. Lys/Glu vs. Glu/Glu 3.00(2.14–4.21) 2.85(2.14–3.81) 2.49(1.83–3.38) 2.80(2.34–3.34)
Dominant model c 4415.3 5313.2 4035.7 13822.5
    Glu/Glu 1437(92.2) 1638(97.6) 1.00 (ref.) 1786(91.6) 1908(97.5) 1.00 (ref.) 1373(91.0) 1495(96.8) 1.00 (ref.) 4596(91.6) 5041(97.3) 1.00 (ref.)
Lys/Lys+Lys/Glu 122(7.8) 41(2.4) 3.38(2.35–4.85) 163(8.4) 49(2.5) 3.52(2.54–4.89) 135(9.0) 50(3.2) 2.87(2.04–4.04) 420(8.4) 140(2.7) 3.29(2.70–4.01)
p.Asn118Ser (rs56316660A>G)
Codominant model c 4464.1 5381.6 4077.2 13982.3
    Asn/Asn 1535(98.5) 1664(99.1) 1.00 (ref.) 1921(98.6) 1933(98.8) 1.00 (ref.) 1490(98.8) 1532(99.2) 1.00 (ref.) 4946(98.6) 5129(99.0) 1.00 (ref.)
    Ser/Asn 19(1.2) 12(0.7) 1.65(0.79–3.41) 22(1.1) 19(1.0) 1.23(0.66–2.30) 15(1.0) 11(0.7) 1.56(0.70–3.48) 56(1.2) 42(0.8) 1.39(0.93–2.08)
    Ser/Ser 5(0.3) 3(0.2) 2.24(0.53–9.47) 6(0.3) 5(0.2) 1.13(0.34–3.75) 3(0.2) 2(0.1) 1.44(0.23–9.14) 14(0.3) 10(0.2) 1.59(0.70–3.60)
Fisher test P value 0.224 0.813 0.612 0.190
Additive model c 4462.1 5379.7 4075.4 13980.4
    Ser/Ser vs. Ser/Asn vs. Asn/Asn 1.57(0.94–2.63) 1.14(0.74–1.77) 1.40(0.76–2.58) 1.32(0.98–1.77)
Dominant model c 4462.2 5379.6 4075.2 13980.4
    Asn/Asn 1535(98.5) 1664(99.1) 1.00 (ref.) 1921(98.6) 1933(98.8) 1.00 (ref.) 1490(98.8) 1532(99.2) 1.00 (ref.) 4946(98.6) 5129(99.0) 1.00 (ref.)
Ser/Ser+Ser/Asn 24(1.5) 15(0.9) 1.76(0.91–3.37) 28(1.4) 24(1.2) 1.21(0.70–2.11) 18(1.2) 13(0.8) 1.54(0.74–3.22) 70(1.5) 52(1.0) 1.43(0.98–2.05)
p.Arg138Cys (rs56106612C>T)
Codominant model c 4464.3 5381.3 4077.7 13982.6
    Arg/Arg 1539(98.7) 1668(99.3) 1.00 (ref.) 1927(98.9) 1940(99.1) 1.00 (ref.) 1491(98.9) 1532(99.1) 1.00 (ref.) 4957(98.8) 5140(99.2) 1.00 (ref.)
    Cys/Arg 15(1.0) 9(0.5) 1.70(0.74–3.91) 18(0.9) 14(0.7) 1.27(0.63–2.56) 15(1.0) 12(0.8) 1.18(0.54–2.56) 48(1.0) 35(0.7) 1.35(0.87–2.10)
    Cys/Cys 5(0.3) 2(0.1) 2.42(0.47–12.6) 4(0.2) 3(0.2) 1.54(0.34–6.93) 2(0.1) 1(0.1) 2.75(0.23–32.8) 11(0.2) 6(0.1) 1.89(0.70–5.16)
Fisher test P value 0.192 0.688 0.627 0.131
Additive model c 4462.4 5379.3 4075.9 13980.7
    Cys/Cys vs. Cys/Arg vs. Arg/Arg 1.63(0.90–2.94) 1.25(0.75–2.10) 1.30(0.68–2.50) 1.36(0.98–1.90)
Dominant model c 4462.5 5379.4 4076.2 13981.0
    Arg/Arg 1539(98.7) 1668(99.3) 1.00 (ref.) 1927(98.9) 1940(99.1) 1.00 (ref.) 1491(98.9) 1532(99.1) 1.00 (ref.) 4957(98.8) 5140(99.2) 1.00 (ref.)
Cys/Cys+Cys/Arg 20(1.3) 11(0.6) 1.83(0.87–3.85) 22(1.1) 17(0.9) 1.31(0.69–2.49) 17(1.1) 13(0.9) 1.28(0.61–2.68) 59(1.2) 41(0.8) 1.43(0.96–2.14)
p.Ala195Thr (rs55800262G>A)
Codominant model c 4464.1 5381.7 4077.2 13982.6
    Ala/Ala 1537(98.6) 1666(99.2) 1.00 (ref.) 1930(99.0) 1941(99.2) 1.00 (ref.) 1487(98.6) 1529(98.9) 1.00 (ref.) 4954(98.8) 5136(99.1) 1.00 (ref.)
    Thr/Ala 18(1.2) 11(0.7) 1.75(0.82–3.73) 13(0.7) 12(0.6) 1.16(0.52–2.56) 16(1.1) 12(0.8) 1.51(0.70–3.27) 47(0.9) 35(0.7) 1.43(0.92–2.24)
    Thr/Thr 4(0.3) 2(0.1) 2.18(0.40–12.0) 6(0.3) 4(0.2) 1.39(0.39–4.97) 5(0.3) 4(0.3) 1.47(0.37–5.90) 15(0.3) 10(0.2) 1.49(0.67–3.35)
Fisher test P value 0.198 0.762 0.703 0.189
Additive model c 4462.2 5379.7 4075.4 13980.9
    Thr/Thr vs. Thr/Ala vs. Ala/Ala 1.63(0.92–2.89) 1.17(0.71–1.93) 1.34(0.80–2.25) 1.32(0.97–1.78)
Dominant model c 4462.2 5379.7 4075.2 13980.6
    Ala/Ala 1537(98.6) 1666(99.2) 1.00 (ref.) 1930(99.0) 1941(99.2) 1.00 (ref.) 1487(98.6) 1529(98.9) 1.00 (ref.) 4954(98.8) 5136(99.1) 1.00 (ref.)
Thr/Thr+Thr/Ala 22(1.5) 13(0.8) 1.82(0.91–3.63) 19(1.0) 16(0.8) 1.22(0.62–2.39) 21(1.4) 16(1.1) 1.50(0.76–2.95) 62(1.2) 45(0.9) 1.45(0.98–2.14)
p.Leu259Phe (rs1053566 C>T)
Codominant model c 4464.2 5381.7 4077.4 13982.4
    Leu/Leu 1543(99.0) 1670(99.4) 1.00 (ref.) 1936(99.3) 1946(99.4) 1.00 (ref.) 1491(98.9) 1532(99.2) 1.00 (ref.) 4970(99.1) 5148(99.3) 1.00 (ref.)
    Phe/Leu 10(0.6) 6(0.4) 1.89(0.68–5.25) 9(0.5) 8(0.4) 1.13(0.43–2.94) 14(0.9) 11(0.7) 1.44(0.63–3.28) 33(0.7) 25(0.5) 1.45(0.85–2.44)
    Phe/Phe 6 (0.4) 3(0.2) 2.28(0.57–9.18) 4(0.2) 3(0.2) 1.52(0.33–6.92) 3(0.2) 2(0.1) 1.82(0.28–11.7) 13(0.3) 8(0.2) 1.83(0.75–4.47)
Fisher test P value 0.300 0.847 0.679 0.250
Additive model c 4462.3 5379.7 4075.4 13980.4
    Phe/Phe vs. Phe/Leu vs. Leu/Leu 1.63(0.91–2.91) 1.19(0.66–2.16) 1.39(0.99–1.96)
Dominant model c 4462.2 5379.8 4075.5 13980.6
    Leu/Leu 1543(99.0) 1670(99.4) 1.00 (ref.) 1936(99.3) 1946(99.4) 1.00 (ref.) 1491(98.9) 1532(99.2) 1.00 (ref.) 4970(99.1) 5148(99.3) 1.00 (ref.)
Phe/Phe+Phe/Leu 16(1.0) 9(0.6) 2.02(0.89–4.61) 13(0.7) 11(0.6) 1.23(0.54–2.76) 17(1.1) 13(0.8) 1.50(0.70–3.18) 44(1.0) 33(0.7) 1.54(0.98–2.42)

a Data were calculated by exact logistic regression adjusted for selected surrounding factors.

b The data comprised the discovery set and two validation sets.

c Akaike information criterion (AIC) value.